# EPLERENONE
> **ANDA207842** · Abbreviated New Drug Application (Generic) · Sponsor: WESTMINSTER PHARMS · Approved 2021-10-25
## Drug
- **FDA Application Number:** ANDA207842
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EPLERENONE
- **Generic name:** EPLERENONE
- **Active ingredients:** EPLERENONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WESTMINSTER PHARMS
- **Manufacturer:** Westminster Pharmaceuticals, LLC
- **First approval:** 2021-10-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207842)
---
*AI Analytics · CC0 1.0*